King Pharmaceuticals KG Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$7.43M-1,786% | —— | -$5.05M-1,078% | $69.93M+12,884% | -$394K— | ||
| $9K-50.0% | $299K+283% | -$2.82M-16,659% | $2.78M— | $18K— | ||
| $1.45M+9,560% | —— | —— | —— | $15K— | ||
| $5.56M+2,369% | -$50.55M-12,779% | $23.36M+6,052% | $8.7M+2,316% | -$245K+37.6% | ||
| -$139K-151% | $810K+321% | $619K+269% | —— | $270K+174% | ||
| $1.34M— | $405K— | $5.49M— | $1.06M— | $0— | ||
| -$512K— | -$2.21M— | -$2.98M— | -$1.33M— | $0— | ||
| -$16.74M— | -$7.04M— | -$22.16M— | -$25.09M— | $0— | ||
| -$15.13M-1,628% | -$65.71M-30,460% | -$9.7M-1,895% | -$19.86M— | -$876K— | ||
| $2.26M— | $2.07M— | $6.08M— | $1.38M— | $0— | ||
| $38.12M— | $47.6M— | $7.88M— | $7.31M— | $0— | ||
| $7K— | $3K— | $17K— | $1K— | $0— | ||
| $474K— | $471K— | $114K— | $490K— | $0— | ||
| -$9.48M— | -$15.68M— | —— | —— | $0— | ||
| $53M— | $42.53M— | $16.08M— | $88.33M— | $0— | ||
| $486K— | —— | —— | —— | $0— | ||
| -$486K— | —— | —— | -$40M— | $0— | ||
| -$548K— | —— | —— | $661K— | $0— | ||
| $36.83M+4,304% | —— | $6.22M+1,379% | $29.13M— | -$876K— | ||
| —— | -$703.25K— | -$703.25K— | -$703.25K— | -$703.25K— | ||
| —— | $2.83M— | $2.83M— | $2.83M— | $2.83M— | ||
| —— | $12K— | $12K— | $12K— | $12K— | ||
| -$681K— | -$1.02M— | -$748K— | -$1.19M— | $0— | ||
| $2.23M— | —— | $2.85M— | —— | $0— | ||
| $1.34M— | $405K— | $5.49M— | $1.06M— | $0— | ||
| —— | -$703.25K— | -$703.25K— | -$703.25K— | -$703.25K— | ||
| -$1K— | $48K— | -$24K— | $0— | $0— | ||
| -$123K— | —— | $144K— | $801K— | $0— | ||
| $5.56M+2,369% | -$50.55M-12,779% | $23.36M+6,052% | $8.7M+2,316% | -$245K+37.6% | ||
| -$16.74M— | -$7.04M— | -$22.16M— | -$25.09M— | $0— | ||
| -$139K-151% | $810K+321% | $619K+269% | —— | $270K+174% | ||
| -$373K— | -$9.18M— | -$637K— | -$93K— | $0— | ||
| -$2.65M— | —— | -$8.95M— | $3.59M— | $0— | ||
| -$512K— | -$2.21M— | -$2.98M— | -$1.33M— | $0— | ||
| -$9.48M— | -$15.68M— | —— | —— | $0— | ||
| $7K— | $3K— | $17K— | $1K— | $0— | ||
| $474K— | $471K— | $114K— | $490K— | $0— | ||
| $2.26M— | $2.07M— | $6.08M— | $1.38M— | $0— | ||
| $44.27M— | —— | —— | —— | $0— | ||
| $38.12M— | $47.6M— | $7.88M— | $7.31M— | $0— | ||
| -$3.02M— | —— | $563K— | $668K— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does King Pharmaceuticals generate?
- King Pharmaceuticals (KG) generated -$110.4M in operating cash flow over the trailing twelve months.
- Where does King Pharmaceuticals's cash flow data come from?
- Every line is extracted from King Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
